FAT1: A Potential Drug Target for Cell-Cell Adhesion and Tissue Repair

Target Name: FAT1

NCBI ID: G2195

FAT1

FAT1: A Potential Drug Target for Cell-Cell Adhesion and Tissue Repair

FAT1 (focal adhesion molecule 1) is a protein that is expressed in a variety of tissues throughout the body, including epithelial, mesenchymal, and neural cells. It is a member of the cadherin family of transmembrane proteins, which are characterized by the presence of a cytoplasmic tail that is involved in cell-cell adhesion.

FAT1 has been identified as a potential drug target and biomarker for a variety of diseases, including cancer. Its unique structure and expression patterns have made it an attractive target for researchers to study, and its involvement in cell-cell adhesion has led to the hypothesis that it may play a role in the regulation of tissue repair and regeneration.

One of the key functions of FAT1 is its role in cell-cell adhesion. Cadherins are a family of transmembrane proteins that are involved in cell-cell adhesion, as well as in cell-cell signaling and tissue repair and regeneration. FAT1 is a member of this family and is involved in the regulation of cell-cell adhesion.

FAT1 is expressed in a variety of tissues throughout the body, including epithelial, mesenchymal, and neural cells. It is highly expressed in epithelial tissue, where it is involved in the regulation of cell-cell adhesion and the formation of tight junctions. It is also expressed in mesenchymal tissue, where it is involved in the regulation of cell-cell adhesion and the formation of chorionic implants. Finally, it is expressed in neural tissue, where it is involved in the regulation of cell-cell adhesion and the formation of axons.

FAT1 has been shown to play a role in the regulation of cell-cell adhesion in a variety of contexts. For example, studies have shown that FAT1 is involved in the regulation of cell-cell adhesion in cancer cells. Specifically, FAT1 has been shown to promote the formation of tight junctions, which are a type of cell-cell adhesion structure that is involved in the regulation of ion and solute transport across cell membranes.

In addition to its role in cell-cell adhesion, FAT1 has also been shown to play a role in the regulation of cell-cell signaling. For example, studies have shown that FAT1 is involved in the regulation of TGF-β signaling, which is a well-known protein that is involved in cell growth, differentiation, and repair.

FAT1 has also been shown to play a role in the regulation of tissue repair and regeneration. For example, studies have shown that FAT1 is involved in the regulation of cell-cell adhesion in the development and maintenance of tissues. Specifically, FAT1 has been shown to promote the formation of chorionic implants, which are structures that are involved in the regulation of tissue repair and regeneration.

In conclusion, FAT1 is a protein that is involved in a variety of processes in the regulation of cell-cell adhesion and tissue repair and regeneration. Its unique structure and expression patterns make it an attractive target for research into the role of cadherins in these processes, and its involvement in cell-cell signaling and tissue repair and regeneration make it a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of FAT1 in these processes and to develop effective treatments for these diseases.

Protein Name: FAT Atypical Cadherin 1

Functions: Plays an essential role for cellular polarization, directed cell migration and modulating cell-cell contact

The "FAT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets